guest@0xbase ~$ read-only mode. Posting requires EU location.

NeoGenomics Launches PanTracer Tissue and PanTracer Tissue HRD for Cancer Care (businesswire.com)

· 344d ago · Report · Spotlight this ·

0xBASE INTEL BRIEF

NeoGenomics launches PanTracer Tissue and PanTracer Tissue HRD
PanTracer Tissue HRD assesses homologous recombination deficiency
Tests support personalized cancer therapy decisions

"NeoGenomics announced the clinical availability of PanTracer Tissue and PanTracer Tissue HRD assays for comprehensive genomic profiling and homologous recombination deficiency assessment in solid tumors."

#NeoGenomics #PanTracer Tissue #HRD

Read article on businesswire.com → | More from businesswire.com

Discussion Matrix

0 segments

no comments yet.